Centessa Pharmaceuticals Statistics
Total Valuation
CNTA has a market cap or net worth of $1.86 billion. The enterprise value is $1.49 billion.
Important Dates
The last earnings date was Monday, March 24, 2025, before market open.
Earnings Date | Mar 24, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CNTA has 133.18 million shares outstanding. The number of shares has increased by 19.02% in one year.
Current Share Class | n/a |
Shares Outstanding | 133.18M |
Shares Change (YoY) | +19.02% |
Shares Change (QoQ) | +13.59% |
Owned by Insiders (%) | 1.40% |
Owned by Institutions (%) | 64.00% |
Float | 91.69M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 4.82 |
P/TBV Ratio | 4.62 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.25, with a Debt / Equity ratio of 0.29.
Current Ratio | 9.25 |
Quick Ratio | 9.09 |
Debt / Equity | 0.29 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -19.93 |
Financial Efficiency
Return on equity (ROE) is -73.93% and return on invested capital (ROIC) is -29.91%.
Return on Equity (ROE) | -73.93% |
Return on Assets (ROA) | -26.82% |
Return on Invested Capital (ROIC) | -29.91% |
Return on Capital Employed (ROCE) | -38.75% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.06M |
Employee Count | 77 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CNTA has paid $2.84 million in taxes.
Income Tax | 2.84M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.44% in the last 52 weeks. The beta is 1.52, so CNTA's price volatility has been higher than the market average.
Beta (5Y) | 1.52 |
52-Week Price Change | +31.44% |
50-Day Moving Average | 16.43 |
200-Day Moving Average | 14.66 |
Relative Strength Index (RSI) | 38.85 |
Average Volume (20 Days) | 1,070,843 |
Short Selling Information
Short Interest | 4.86M |
Short Previous Month | 5.46M |
Short % of Shares Out | 4.32% |
Short % of Float | n/a |
Short Ratio (days to cover) | 4.53 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -201.06M |
Pretax Income | -163.67M |
Net Income | -235.76M |
EBITDA | -200.71M |
EBIT | -201.06M |
Earnings Per Share (EPS) | -$2.06 |
Full Income Statement Balance Sheet
The company has $482.18 million in cash and $117.83 million in debt, giving a net cash position of $364.35 million or $2.74 per share.
Cash & Cash Equivalents | 482.18M |
Total Debt | 117.83M |
Net Cash | 364.35M |
Net Cash Per Share | $2.74 |
Equity (Book Value) | 401.55M |
Book Value Per Share | 3.03 |
Working Capital | 478.41M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$142.06 million and capital expenditures -$34,000, giving a free cash flow of -$142.09 million.
Operating Cash Flow | -142.06M |
Capital Expenditures | -34,000 |
Free Cash Flow | -142.09M |
FCF Per Share | -$1.07 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |